Uncategorized
VIDEO: Encapsulated cell therapy shows promising results in MacTel and glaucoma
SAN DIEGO ― At the Ophthalmology Innovation Summit, Rich Small, CPA, CEO of Neurotech Pharmaceuticals, discusses the company’s encapsulated cell therapy’s progress in clinical trials for macular telangiectasia as well as neuroprotection in glaucoma.